<DOC>
	<DOCNO>NCT01833455</DOCNO>
	<brief_summary>The purpose study determine reduction premature ventricular contraction ( PVC ) burden result decrease blood pressure , sympathetic outflow , plasma catecholamine improvement baroreflex gain . Flecainide use PVC suppression randomize , double-blinded , crossover fashion .</brief_summary>
	<brief_title>Premature Ventricular Contractions ( PVCs ) Blood Pressure Control</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Ventricular Premature Complexes</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<criteria>Frequent symptomatic premature ventricular contraction ( PVCs ) ( &gt; 10 % total QRSs 24hour Holter ) Willingness participate research Age &gt; 65 year old Pacemaker implantation Implantable cardioverter defibrillator implantation require pace Sick sinus syndrome Atrioventricular ( AV ) block Left ventricular dysfunction define leave ventricular ejection fraction &lt; 50 % History myocardial infarction coronary artery disease Severe leave ventricular hypertrophy ( wall thickness &gt; 1.5 cm echocardiography perform within 3 month enrollment ) Severe liver dysfunction Creatinine clearance 35 mL/min/1.73 square meter less Pregnancy Known hypersensitivity drug QRS duration &gt; 120 ms Recent change blood pressure medication within 30 day enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>